Study of chronic thromboembolic pulmonary hypertension via analyzing the genome and transomics analyses.
Not Applicable
- Conditions
- chronic thromboembolic pulmonary hypertension
- Registration Number
- JPRN-UMIN000049092
- Lead Sponsor
- Kobe University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with HBV, HCV or HIV virus, patients under using prednisolone, cancer patients under treatment or patients who have history of cancer, patients with psychosis having trouble to get consent form, or patients with dementia who need treatment.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The involvement of somatic gene mutation in the pathophysiology of chronic thromboembolic pulmonary hypertension.
- Secondary Outcome Measures
Name Time Method Epigenome, transcriptome, and proteome data of the lesions. Plasma metabolome data.